Neutrophil adherence to endothelial cells (ECs) under conditions of flow occurs in successive steps, including selectindependent primary adhesion and CD18-dependent secondary adhesion. We used a parallel-plate flow chamber to assess the steps in T cell adherence in vitro. Detailed studies of acute inflammatory processes suggest that neutrophil/endothelial cell (EC)' interaction can be divided into several successive steps. These steps include primary adhesion, in which free-flowing neutrophils bind and roll slowly along the surface of activated endothelium, secondary firm adhesion of the rolling cells, and subsequent transmigration. Distinct families of adhesion molecules have been shown to participate in the primary and secondary adhesive events for neutrophils. Primary adhesion involves all three members of the selectin family (1-5) and their oligosaccharide ligands, while secondary adhesion involves 62 (CD18) integrins on neutrophils (1) and immunoglobulin gene superfamily counterreceptors on EC (primarily intercellular adhesion molecule-I [ICAM-1]) (2). Selectin-ligand interactions are activation independent, are rapid enough to bind free-flowing neutrophils, and appear to break in such a way as to allow adherent leukocytes to roll slowly along the endothelium (6, 7). In contrast, CD18 integrin-ligand interactions are activation dependent (i.e., high avidity can be induced through a conformation change), are not able to initiate adhesion under flow conditions, but can mediate highly stable adhesion under static conditions or once binding is initiated by selectins (1, 4, 8, 9) .
Detailed studies of acute inflammatory processes suggest that neutrophil/endothelial cell (EC)' interaction can be divided into several successive steps. These steps include primary adhesion, in which free-flowing neutrophils bind and roll slowly along the surface of activated endothelium, secondary firm adhesion of the rolling cells, and subsequent transmigration. Distinct families of adhesion molecules have been shown to participate in the primary and secondary adhesive events for neutrophils. Primary adhesion involves all three members of the selectin family (1) (2) (3) (4) (5) and their oligosaccharide ligands, while secondary adhesion involves 62 (CD18) integrins on neutrophils (1) and immunoglobulin gene superfamily counterreceptors on EC (primarily intercellular adhesion molecule-I [ICAM-1]) (2) . Selectin-ligand interactions are activation independent, are rapid enough to bind free-flowing neutrophils, and appear to break in such a way as to allow adherent leukocytes to roll slowly along the endothelium (6, 7) . In contrast, CD18 integrin-ligand interactions are activation dependent (i.e., high avidity can be induced through a conformation change), are not able to initiate adhesion under flow conditions, but can mediate highly stable adhesion under static conditions or once binding is initiated by selectins (1, 4, 8, 9) .
Fewer details are known about the interactions between lymphocytes and EC during extravasation at sites of inflammation. The selectin and CD18 integrin adhesion pathways, as well as other pathways not used by neutrophils, including the a401 integrin (VLA-4) and a4f37 integrin pathways (which preferentially bind to the EC ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-I , respectively), have been implicated in lymphocyte-EC recognition (10, 11) . However, most studies of the adhesive functions of these pathways have used assays which do not discriminate the relative participation of these pathways in primary and secondary adhesion. It is therefore still not clear if lymphocyte-EC adhesive interactions under flow are analogous to the multistep process described for neutrophils, and if so, which receptors contribute at each stage.
This study addresses these issues by examining the behavior of purified peripheral blood T cells in static and flow adhesion assays using two model systems: (a) murine L cell monolayers transfected with a single human receptor (E-selectin, ICAM-1, or VCAM-1) to examine adhesion mediated by single adhesion pathways; and (b) cultured human umbilical vein EC (HU-VEC) monolayers stimulated with cytokines to explore possible cooperative interactions between the various adhesion molecule pairs in a physiologically relevant cell type. Monoclonal antibody (mAb) blocking was used to confirm the specificity of interaction using the transfected cells and to analyze the contri-butions of particular adhesion pathways with the HUVECs. Our results confirm that T cell interactions with 24-h IL-I -stimulated HUVEC monolayers involve distinct primary and secondary adhesion steps and use both ICAM-l/CD18 integrin and VCAM-I/a431 integrin interactions. However, we were unable to define the adhesion molecules that account for primary adhesion of T cells to activated EC monolayers and suggest that this event may be independent of the three known members of the selectin family.
Methods
Isolation of T lymphocytes. Human peripheral blood T cells were obtained by centrifugation of whole blood through Ficoll-Hypaque (Histopaque 1077; Sigma Chemical Co., St. Louis, MO) and negative selection using a T cell enrichment column (R&D Systems, Inc., Minneapolis, MN). Preparations were > 95% CD3+ and > 99% viable and were labeled when necessary using the fluorescent DNA-binding dye Hoescht 33342 (bis-benzamide; Sigma Chemical Co.; reference 12). Chymotrypsin treatment to remove surface L-selectin was performed as described elsewhere (13) . Cutaneous lymphocyte antigen (CLA)+ CD45RA-and CLA-CD45RA-T cell populations were prepared using a FACStarP"US flow cytometer (Becton Dickinson, Mountain View, CA), as described previously (14) .
Tissue culture. (14) (15) (16) (17) . In static and flow adhesion assays, L cell and HUVEC monolayers were treated with mAbs for 30 min at 37°C before use. T cells were treated with mAbs for 30 min at room temperature before use. Experiments were also run in which T cells were treated with mAbs at 37 or 4°C instead of at room temperature to check for possible activating or inhibitory side effects of the mAb treatments, and no differences in binding were observed. In most experiments, cells were pretreated with antibodies before use in the flow system, since preliminary experiments showed identical results for pretreatment alone and pretreatment with inclusion of mAb in the flow buffer.
Adhesion assays. Physiological flow conditions were produced in vitro using a flow chamber with parallel-plate geometry as described previously (2) . The chamber produces a well-defined laminar flow over monolayers grown in 35-mm tissue culture dishes and was used for both static and flow adhesion assays.
In the static assays, a suspension of 5 x 106 fluorescently labeled T cells/ml in 37°C Dulbecco's phosphate-buffered saline (D-PBS) was infused into the chamber and allowed to settle onto the monolayer for a period of 2 min. All of the T cells settle and contact the monolayer within 1.5 min. Nonadherent cells were removed by flowing D-PBS through the chamber for 15 s at a wall shear stress of 2.0 dyn/cm2.
During all experiments, the flow system was maintained at 37°C in a warm air box surrounding the microscope. Images were acquired using videomicroscopy (Diaphot-TMD microscope from Nikon, Inc., Garden City, NY; Hamamatsu CI000 video camera from Hamamatsu Photonics, Bridgewater, NJ) for four fields of view (x20 objective; 0.28 mm2 fields) both before and after rinsing. The average number of cells per field of view after rinsing was divided by that before rinsing to give the percentage of cells adhering for that experiment. Values were then averaged for a minimum of n = 4 experiments using various T cell donors and various pools of HUVECs.
In the flow adhesion assay, a suspension of 106 T cells/ml in D-PBS was perfused through the chamber at a wall shear stress of 2.0 dyn/cm2. A single field of view was monitored during the 10 min of the experiment, and at the end four fields of view were monitored for 15 s each. All experiments were videotaped for later analysis (Sony SLV400 VCR; Sony Corp., Park Ridge, NJ). Three quantities were measured in the analysis: the total interacting cells during the entire 10-min experiment, the number of stably adherent cells at the end, and the average rolling velocity. The total number of interacting cells is the number of cells which interact with the monolayer (either rolling or immediately arrested) for at least 1 s and was determined manually by reviewing the videotapes. Stably adherent cells accumulate throughout each experiment and were counted for each of four fields of view at the end. Only cells which remained stationary for at least 5 s were counted as stably adherent cells. Rolling velocities were measured as described previously (2) . Briefly, after -9 min of flow we acquired several 4-s "maximization" images (see Fig. 5 ) using a digital image processing system (Sun Microsystems, Mountain View, CA; Inovision Corp., Durham, NC). The lengths of the blurs divided by the acquisition time (4 s) give the rolling velocity. In static and flow adhesion assays using L cell monolayers, T cells were fluorescently labeled to allow accurate image analysis, while in experiments with HUVEC monolayers T cells were left unlabeled and could be readily distinguished with phase contrast. Control experiments for effects of the labeling were performed using unlabeled T cells, and no differences were found between labeled and unlabeled T cells. Fig. 2 shows the results of experiments to determine which of these adhesion pathways support initial attachment under flow conditions (primary adhesion). At 2.0 dyn/cm2 wall shear stress, the L-ELAM and L-VCAM-l monolayers supported primary adhesion of T cells while the L-ICAM-1 monolayer did not. Here again, the mAbs specifically and completely blocked the appropriate adhesion pathways. Although T cells adhered to both L-ELAM and L-VCAM-I monolayers under flow, there was an important qualitative difference in this adhesion (Fig.  3) : the L-ELAM monolayers supported rolling with very little stable adhesion, whereas L-VCAM-1 monolayers supported predominantly an immediate arrest pattem of interaction with -70% becoming stably adherent. Some T cells did roll on the L-VCAM-l monolayers, but these were fewer than 10% of the interacting cells. Adhesion of T cells to L cells expressing the six-domain form of VCAM-l was essentially identical to results with the seven-domain form (data not shown). We also observed that the T cells do not appear to be moving unusually slowly when they adhere to the L-VCAM-l cells, nor do they appear to adhere preferentially to either the leading or trailing edges of these cells, suggesting that topography of the L-VCAM-1 monolayers does not influence primary adhesion. (Fig. 3) .
We also performed experiments using L-ELAM monolayers and memory/effector T cells sorted according to expression of the major T cell E-selectin ligand CLA ( 14, 18, 19) (20) (21) (22) (23) . HUVECs did not stain with anti-P-selectin mAb GI after IL-1 or IL-1 + IL-4 stimulation for 24 h, although we have previously used this mAb to demonstrate P-selectin expression soon after histamine stimulation (2) .
In adhesion experiments under static conditions (Fig. 4) , there was no apparent contribution of E-selectin, consistent with its low level of expression on 24-h stimulated HUVECs (Table  I ). On 24-h IL-1-stimulated HUVECs, there were comparable contributions of the VCAM-1 and ICAM-1 pathways, but on IL- (2, 4, 26) .
Quantitation of adhesion under flow revealed that -50% of the T cells interacting with 24-h IL-1-stimulated HUVECs became stably adherent (Fig. 6) . PMA stimulation of the T cells reduced primary adhesion somewhat and markedly altered the nature of the interactions, promoting immediate arrest that remained stable. Primary adhesion was not significantly reduced by any of the blocking mAbs (Fig. 7) , and using anti-L-selectin and anti-E-selectin mAbs together also had no significant effect (data not shown). Additional studies were carried out to assess a possible role for L-selectin. Treatment of the T cells with chymotrypsin to remove surface L-selectin failed to reduce the primary adhesion, and treatment of 24-h IL-l -stimulated HUVECs with L-selectin-Ig chimera (generously supplied by Dr. S. Watson, Genentech Inc., South San Francisco, CA) at concentrations of 10 and 100 pg/ml (27) (Table I) , which detects the high affinity L-selectin ligands expressed by high endothelial venules in peripheral lymph node and other sites (17) . L-selectin lymphoid cell transfectants also failed to adhere to the stimulated HUVECs in the flow assay (data not shown).
Secondary adhesion to 24-h IL-1-stimulated HUVECs was inhibited by 90% using mAbs which block the a461 integrin/ VCAM-1 and 62 integrin/ICAM-l pathways (Fig. 7) . Most interacting cells in these experiments rolled along the HUVEC monolayers. Stimulation with both IL-1 and IL-4 completely prevented primary adhesion of T cells (Fig. 6) , although the secondary adhesion mechanisms seemed to be intact since these monolayers supported high levels of both VCAM-1-and ICAM-1 -dependent adhesion of T cells under static conditions (Fig. 4) . VCAM-1 is highly expressed on these cells (Table  I) , so the lack of primary adhesion contrasts with the primary adhesion seen with the L-VCAM-l monolayers. Surface distribution does not appear to explain this difference since immunofluorescence studies of HUVECs and L cells showed that VCAM-1 has a relatively uniform surface distribution on both L cells and stimulated HUVECs. T cell rolling velocities. Fig. 8 presents T cell rolling velocities under various conditions. These T cell rolling velocities agree well with previously reported lymphocyte rolling velocities in vivo (28) as well as previously reported neutrophil rolling velocities both in vitro (2, 3, 5) and in vivo (29, 30) . Blockade of each integrin pathway increased rolling velocity, similar to the effect of CD18 integrin/ICAM-l interactions on rolling velocity which has been reported for neutrophils (2, 8, 9, 31) . their immunoglobulin superfamily ligands (primarily ICAM-l ) for secondary adhesion (1) (2) (3) None of the other adhesion molecules previously implicated in lymphocyte/EC interactions in humans appear likely to account for the primary adhesion observed on 24-h IL-i -treated HUVECs. The lack of inhibition of the anti-a4 mAb HP2/1 would appear to exclude a role for a4,37/MAdCAM-I interactions ( II), as this mAb specifically inhibits the a437-dependent binding of human T cells to mouse MAdCAM-I (Rott, L., and E. Butcher, personal communication). An mAb (Hermes-3) and a polyclonal antiserum against CD44 that have been shown previously to inhibit in vitro lymphocyte-EC interactions (34, 35) also had no effect on the observed interaction (data not shown). The observation that platelet-endothelial cell adhesion molecule-I is similarly expressed on unstimulated, IL-I -stimulated, and IL-1 + IL-4-stimulated HUVECs suggests that this molecule is not responsible for the primary adhesion. Vascular adhesion protein-I is not expressed on HUVECs, and lymphocyte-vascular adhesion protein-2 is constitutively expressed and not inducible on HUVECs, so these recently described adhesion molecules do not appear to play a role in this system (36, 37) .
Secondary adhesion of T cells to 24-h IL-i -stimulated HU-
VEC monolayers appears to be almost completely dependent on the a4,61/VCAM-l and /62 integrin/ICAM-1 pathways. Additionally, several observations suggest that triggering of a highavidity state of these integrin pathways is an important event in the transition from primary to secondary adhesion. First, stable adhesion was reduced minimally if either integrin pathway was blocked alone, but almost completely if both pathways were blocked, so that under the circumstances of these studies, either pathway appears to provide a sufficient number of receptors for stable adhesion of T cells. Second, evaluation of T cell rolling velocities demonstrated that both sets of integrins contribute to slowing cells which roll, although the interactions are evidently not strong enough to fully stop the cells. Finally, phorbol ester pretreatment, which apparently increases the avidity of binding of both integrin pathways, significantly increased the fraction of interacting cells which adhere stably. Taken together, these observations suggest that for many interacting T cells integrins are initially in a low-avidity state, but for those cells which eventually adhere stably there is a transition to a high-avidity state during which one or both of the integrin pathways take over the majority of the interaction.
The primary adhesion mechanism for T cell binding to 24-h IL-1-stimulated HUVECs appears to be able to function by itself to mediate a rolling interaction, as demonstrated by the experiments with both integrin pathways blocked. The integrin pathways mediating secondary adhesion, however, are apparently unable to function without a primary adhesion mechanism to tether T cells which are moving with the fluid stream. This is most clearly shown in experiments with combined IL-1 + IL-4 stimulation of HUVEC monolayers, where the primary adhesive mechanism is not evident but the secondary mechanisms develop high levels of adhesion under static conditions. Thus, there is now evidence that T cells can use at least a twostep cascade to adhere to activated ECs under conditions of flow.
